Cargando…
Late Treatment for COVID-19 With Convalescent Plasma
Autores principales: | Senefeld, Jonathon W., Paneth, Nigel S., Carter, Rickey E., Wright, R. Scott, Fairweather, DeLisa, Bruno, Katelyn A., Joyner, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634046/ https://www.ncbi.nlm.nih.gov/pubmed/36344142 http://dx.doi.org/10.1016/j.chest.2022.07.029 |
Ejemplares similares
-
In Reply — Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Joyner, Michael. J., et al.
Publicado: (2020) -
In Reply—How Safe Is COVID-19 Convalescent Plasma?
por: Joyner, Michael J., et al.
Publicado: (2021) -
Use of convalescent plasma in the treatment of COVID-19
por: Joyner, Michael J., et al.
Publicado: (2023) -
Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality
por: Casadevall, Arturo, et al.
Publicado: (2021) -
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
por: Klassen, Stephen A., et al.
Publicado: (2021)